B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage

British Journal of Haematology

Volumn 153, Issue 1, 2011, Pages 3-14

  Dal Bo, Michele ^a   Del Giudice, Ilaria ^b   Bomben, Riccardo ^a   Capello, Daniela ^c   Bertoni, Francesco ^d   Forconi, Francesco ^e   Laurenti, Luca ^f   Rossi, Davide ^c   Zucchetto, Antonella ^a   Pozzato, Gabriele ^g   Marasca, Roberto ^h   Efremov, Dimitar G ⁱ   Guarini, Anna ^b   Del Poeta, Giovanni ^j   Foà, Robin ^b   Gaidano, Gianluca ^c   Gattei, Valter ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^e UNIVERSITY OF SIENA   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF TRIESTE   (Italy)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁱ ICGEB Outstation Monterotondo   (Italy)

^j UNIVERSITY OF ROME TOR VERGATA   (Italy)

more..

Author keywords

B cell receptor; Chronic lymphocytic leukaemia; IGHV3 subgroup; Immunoglobulin; Prognosis

Indexed keywords

B LYMPHOCYTE RECEPTOR;

CANCER CONTROL; CANCER GENETICS; CANCER GROWTH; CANCER REGRESSION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ACTIVITY; DISEASE COURSE; GENE; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENE REARRANGEMENT; GENETIC SCREENING; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE 3 21 GENE; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE 3 23 GENE; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE 3 30 GENE; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE 3 72 GENE; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE 3 GENE; LEUKEMIA REMISSION; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

GENE EXPRESSION; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROGNOSIS; RECEPTORS, ANTIGEN, B-CELL;

EID: 79952593462     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08440.x     Document Type: Review

References (92)

1. Abramenko, I., Bilous, N., Kryachok, I., Filonenko, I., Pilipenko, G., Chumak, A., Bazyka, D. & Bebeshko, V. (2007) IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine. Experimental Oncology, 29, 226-230.
2. Bernard, M., Drenou, B., Pangault, C., Dauriac, C., Fauchet, R., LePrise, P.Y. & Lamy, T. (1999) Spontaneous phenotypic and molecular blood remission in a case of chronic lymphocytic leukaemia. British Journal of Haematology, 107, 213-214.
3. Bilous, N., Bomben, R., Dal, B.M., Capello, D., Forconi, F., Laurenti, L., Bertoni, F., Efremov, D.G., Marasca, R., Del, P.G., Martina, Z., Kryachouk, I., Dyagil, I., Gaidano, G., Chumak, A., Gattei, V. & Abramenko, I. (2010) Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort. Leukemia & Lymphoma, 51, 822-838.
4. Bomben, R., Dal Bo, M., Capello, D., Benedetti, D., Marconi, D., Zucchetto, A., Forconi, F., Maffei, R., Ghia, E.M., Laurenti, L., Bulian, P., Del Principe, M.I., Palermo, G., Thorselius, M., Degan, M., Campanini, R., Guarini, A., Del Poeta, G., Rosenquist, R., Efremov, D.G., Marasca, R., Foa, R., Gaidano, G. & Gattei, V. (2007) Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood, 109, 2989-2998.
5. Bomben, R., Dal, B.M., Capello, D., Forconi, F., Maffei, R., Laurenti, L., Rossi, D., Del Principe, M.I., Zucchetto, A., Bertoni, F., Rossi, F.M., Bulian, P., Cattarossi, I., Ilariucci, F., Sozzi, E., Spina, V., Zucca, E., Degan, M., Lauria, F., Del, P.G., Efremov, D.G., Marasca, R., Gaidano, G. & Gattei, V. (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. British Journal of Haematology, 144, 492-506.
6. Bomben, R., Dal, B.M., Capello, D., Forconi, F., Bertoni, F., Maffei, R., Laurenti, L., Rossi, D., Zucca, E., Degan, M., Marasca, R., Efremov, D.G., Del, P.G., Gaidano, G. & Gattei, V. (2010a) IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia. British Journal of Haematology, 149, 299-302.
7. Bomben, R., Dal-Bo, M., Benedetti, D., Capello, D., Forconi, F., Marconi, D., Bertoni, F., Maffei, R., Laurenti, L., Rossi, D., Del Principe, M.I., Luciano, F., Sozzi, E., Cattarossi, I., Zucchetto, A., Rossi, F.M., Bulian, P., Zucca, E., Nicoloso, M.S., Degan, M., Marasca, R., Efremov, D.G., Del, P.G., Gaidano, G. & Gattei, V. (2010b) Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. Clinical Cancer Research, 16, 620-628.
8. Borche, L., Lim, A., Binet, J.L. & Dighiero, G. (1990) Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood, 76, 562-569.
9. Broker, B.M., Klajman, A., Youinou, P., Jouquan, J., Worman, C.P., Murphy, J., Mackenzie, L., Quartey-Papafio, R., Blaschek, M., Collins, P., Lal, S. & Lydyard, P.M. (1988) Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies. Journal of Autoimmunity, 1, 469-481.
10. Burger, J.A., Quiroga, M.P., Hartmann, E., Burkle, A., Wierda, W.G., Keating, M.J. & Rosenwald, A. (2009) High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood, 113, 3050-3058.
11. Calin, G.A., Ferracin, M., Cimmino, A., Di, L.G., Shimizu, M., Wojcik, S.E., Iorio, M.V., Visone, R., Sever, N.I., Fabbri, M., Iuliano, R., Palumbo, T., Pichiorri, F., Roldo, C., Garzon, R., Sevignani, C., Rassenti, L., Alder, H., Volinia, S., Liu, C.G., Kipps, T.J., Negrini, M. & Croce, C.M. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine, 353, 1793-1801.
12. Calin, G.A., Cimmino, A., Fabbri, M., Ferracin, M., Wojcik, S.E., Shimizu, M., Taccioli, C., Zanesi, N., Garzon, R., Aqeilan, R.I., Alder, H., Volinia, S., Rassenti, L., Liu, X., Liu, C.G., Kipps, T.J., Negrini, M. & Croce, C.M. (2008) MiR-15a and miR-16-1 cluster functions in human leukemia. Proceedings of the National Academy of Sciences of the United States of America, 105, 5166-5171.
13. Capello, D., Guarini, A., Berra, E., Mauro, F.R., Rossi, D., Ghia, E., Cerri, M., Logan, J., Foa, R. & Gaidano, G. (2004) Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia, 18, 1941-1947.
14. Capello, D., Zucchetto, A., Degan, M., Bomben, R., Dal Bo, M., Efremov, D.G., Laurenti, L., Del Poeta, G., Gaidano, G. & Gattei, V. (2006) Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL). Leukemia Research, 30, 1197-1199.
15. Catera, R., Silverman, G.J., Hatzi, K., Seiler, T., Didier, S., Zhang, L., Herve, M., Meffre, E., Oscier, D.G., Vlassara, H., Scofield, R.H., Chen, Y., Allen, S.L., Kolitz, J., Rai, K.R., Chu, C.C. & Chiorazzi, N. (2008) Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Molecular Medicine, 14, 665-674.
16. Cernuda-Morollon, E. & Ridley, A.J. (2006) Rho GTPases and Leukocyte Adhesion Receptor Expression and Function in Endothelial Cells. Circulation Research, 98, 757-767.
17. Chiorazzi, N., Rai, K.R. & Ferrarini, M. (2005) Chronic Lymphocytic Leukemia. The New England Journal of Medicine, 352, 804-815.
18. Dal-Bo, M., Bertoni, F., Forconi, F., Zucchetto, A., Bomben, R., Marasca, R., Deaglio, S., Laurenti, L., Efremov, D.G., Gaidano, G., Del, P.G. & Gattei, V. (2009) Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. Journal of Translational Medicine, 7, 76.
19. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840-1847.
20. Damle, R.N., Ghiotto, F., Valetto, A., Albesiano, E., Fais, F., Yan, X.J., Sison, C.P., Allen, S.L., Kolitz, J., Schulman, P., Vinciguerra, V.P., Budde, P., Frey, J., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (2002) B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood, 99, 4087-4093.
21. Degan, M., Bomben, R., Dal Bo, M., Zucchetto, A., Nanni, P., Rupolo, M., Steffan, A., Attadia, V., Ballerini, P.F., Damiani, D., Pucillo, C., Del Poeta, G., Colombatti, A. & Gattei, V. (2004) Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. British Journal of Haematology, 126, 29-42.
22. Del Giudice, I., Chiaretti, S., Tavolaro, S., De Propris, M.S., Maggio, R., Mancini, F., Peragine, N., Santangelo, S., Marinelli, M., Mauro, F.R., Guarini, A. & Foa, R. (2009) Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases. Blood, 114, 638-646.
23. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. The New England Journal of Medicine, 343, 1910-1916.
24. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S.L., Schulman, P., Vinciguerra, V.P., Rai, K., Rassenti, L.Z., Kipps, T.J., Dighiero, G., Schroeder, H.W., Jr., Ferrarini, M. & Chiorazzi, N. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation, 102, 1515-1525.
25. Falt, S., Merup, M., Tobin, G., Thunberg, U., Gahrton, G., Rosenquist, R. & Wennborg, A. (2005) Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia. Blood, 106, 681-689.
26. Foa, R., Catovsky, D., Brozovic, M., Marsh, G., Ooyirilangkumaran, T., Cherchi, M. & Galton, D.A. (1979) Clinical staging and immunological findings in chronic lymphocytic leukemia. Cancer, 44, 483-487.
27. Forch, P. & Valcarcel, J. (2001) Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1. Apoptosis, 6, 463-468.
28. Fulci, V., Chiaretti, S., Goldoni, M., Azzalin, G., Carucci, N., Tavolaro, S., Castellano, L., Magrelli, A., Citarella, F., Messina, M., Maggio, R., Peragine, N., Santangelo, S., Mauro, F.R., Landgraf, P., Tuschl, T., Weir, D.B., Chien, M., Russo, J.J., Ju, J., Sheridan, R., Sander, C., Zavolan, M., Guarini, A., Foa, R. & Macino, G. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood, 109, 4944-4951.
29. Garg, A., Barnes, P.F., Porgador, A., Roy, S., Wu, S., Nanda, J.S., Griffith, D.E., Girard, W.M., Rawal, N., Shetty, S. & Vankayalapati, R. (2006) Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. Journal of Immunology, 177, 6192-6198.
30. Gattei, V., Bulian, P., Del Principe, M.I., Zucchetto, A., Maurillo, L., Buccisano, F., Bomben, R., Dal-Bo, M., Luciano, F., Rossi, F.M., Degan, M., Amadori, S. & Del, P.G. (2008) Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood, 111, 865-873.
31. Ghia, P., Stamatopoulos, K., Belessi, C., Moreno, C., Stella, S., Guida, G., Michel, A., Crespo, M., Laoutaris, N., Montserrat, E., Anagnostopoulos, A., Dighiero, G., Fassas, A., Caligaris-Cappio, F. & Davi, F. (2005) Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood, 105, 1678-1685.
32. Ghia, E.M., Jain, S., Widhopf, G.F., Rassenti, L.Z., Keating, M.J., Wierda, W.G., Gribben, J.G., Brown, J.R., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A.W. & Kipps, T.J. (2008) Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection. Blood, 111, 5101-5108.
33. Giudicelli, V., Duroux, P., Ginestoux, C., Folch, G., Jabado-Michaloud, J., Chaume, D. & Lefranc, M.P. (2006) IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Research, 34, D781-D784.
34. Gomez Garcia, E.B., van Lochem, E.G., van Lom, K. & Hooijkaas, H. (2002) Spontaneous remission of b-chronic lymphocytic leukaemia. British Journal of Haematology, 119, 874-875.
35. Guarini, A., Gaidano, G., Mauro, F.R., Capello, D., Mancini, F., De Propris, M.S., Mancini, M., Orsini, E., Gentile, M., Breccia, M., Cuneo, A., Castoldi, G. & Foa, R. (2003) Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood, 102, 1035-1041.
36. Guarini, A., Chiaretti, S., Tavolaro, S., Maggio, R., Peragine, N., Citarella, F., Ricciardi, M.R., Santangelo, S., Marinelli, M., De Propris, M.S., Messina, M., Mauro, F.R., Del, Giudice I. & Foa, R. (2008) BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood, 112, 782-792.
37. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848-1854.
38. Hamblin, T.J., Orchard, J.A., Gardiner, A., Oscier, D.G., Davis, Z. & Stevenson, F.K. (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood, 95, 2455-2457.
39. Han, T. & Sokal, J.E. (1971) Spontaneous remission of leukemic lymphoproliferative disease. Cancer, 27, 586-595.
40. Hillson, J.L., Karr, N.S., Oppliger, I.R., Mannik, M. & Sasso, E.H. (1993) The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. Journal of Experimental Medicine, 178, 331-336.
41. Ireton, K. (2007) Entry of the bacterial pathogen Listeria monocytogenes into mammalian cells. Cellular Microbiology, 9, 1365-1375.
42. Karube, Y., Tanaka, H., Osada, H., Tomida, S., Tatematsu, Y., Yanagisawa, K., Yatabe, Y., Takamizawa, J., Miyoshi, S., Mitsudomi, T. & Takahashi, T. (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Science, 96, 111-115.
43. Kipps, T.J., Tomhave, E., Pratt, L.F., Duffy, S., Chen, P.P. & Carson, D.A. (1989) Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 86, 5913-5917.
44. Kirkham, P.M., Mortari, F., Newton, J.A. & Schroeder, H.W., Jr (1992) Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO Journal, 11, 603-609.
45. Klein, U. & Dalla-Favera, R. (2008) Germinal centres: role in B-cell physiology and malignancy. Nature Reviews. Immunology, 8, 22-33.
46. Klein, U., Tu, Y., Stolovitzky, G.A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A. & Dalla-Favera, R. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. Journal of Experimental Medicine, 194, 1625-1638.
47. Krober, A., Benner, A., Buhler, A., Dohner, H. & Stilgenbauer, S. (2002) Multivariate survival analysis of specific VH-Genes in CLL: V3-21 and V3-23 are prognostic factors indipendently of the vh mutation status (Abstract). Blood, 100, 196a-197a.
48. Lanemo, M.A., Hellqvist, E., Sidorova, E., Soderberg, A., Baxendale, H., Dahle, C., Willander, K., Tobin, G., Backman, E., Soderberg, O., Rosenquist, R., Horkko, S. & Rosen, A. (2008) A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood, 111, 3838-3848.
49. Lauria, F., Foa, R., Mantovani, V., Fierro, M.T., Catovsky, D. & Tura, S. (1983) T-cell functional abnormality in B-chronic lymphocytic leukaemia: evidence of a defect of the T-helper subset. British Journal of Haematology, 54, 277-283.
50. Lin, K., Manocha, S., Harris, R.J., Matrai, Z., Sherrington, P.D. & Pettitt, A.R. (2003) High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment. Blood, 102, 1145-1146.
51. Lu, D., Zhao, Y., Tawatao, R., Cottam, H.B., Sen, M., Leoni, L.M., Kipps, T.J., Corr, M. & Carson, D.A. (2004) Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc.Natl.Acad.Sci.U S.A, 101, 3118-3123.
52. Maloum, K., Davi, F., Merle-Beral, H., Pritsch, O., Magnac, C., Vuillier, F., Dighiero, G., Troussard, X., Mauro, F.F. & Benichou, J. (2000) Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood, 96, 377-379.
53. Matthews, C., Catherwood, M., Morris, T.C. & Alexander, H.D. (2004) Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leukemia & Lymphoma, 45, 1899-1904.
54. Messmer, B.T., Albesiano, E., Messmer, D. & Chiorazzi, N. (2004) The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood, 103, 3490-3495.
55. Messmer, B.T., Raphael, B.J., Aerni, S.J., Widhopf, G.F., Rassenti, L.Z., Gribben, J.G., Kay, N.E. & Kipps, T.J. (2009) Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia. Leukemia Research, 33, 368-376.
56. Mor-Vaknin, N., Punturieri, A., Sitwala, K. & Markovitz, D.M. (2003) Vimentin is secreted by activated macrophages. Nat.Cell Biol., 5, 59-63.
57. Moshnikova, A., Frye, J., Shay, J.W., Minna, J.D. & Khokhlatchev, A.V. (2006) The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. Journal of Biological Chemistry, 281, 8143-8152.
58. Murray, F., Darzentas, N., Hadzidimitriou, A., Tobin, G., Boudjogra, M., Scielzo, C., Laoutaris, N., Karlsson, K., Baran-Marzsak, F., Tsaftaris, A., Moreno, C., Anagnostopoulos, A., Caligaris-Cappio, F., Vaur, D., Ouzounis, C., Belessi, C., Ghia, P., Davi, F., Rosenquist, R. & Stamatopoulos, K. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood, 111, 1524-1533.
59. Odegard, V.H. & Schatz, D.G. (2006) Targeting of somatic hypermutation. Nature Reviews. Immunology, 6, 573-583.
60. Orchard, J.A., Ibbotson, R.E., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P.W., Hamblin, T.J., Staudt, L.M. & Oscier, D.G. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet, 363, 105-111.
61. Oscier, D.G., Thompsett, A., Zhu, D. & Stevenson, F.K. (1997) Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood, 89, 4153-4160.
62. Ota, T. & Nei, M. (1994) Divergent evolution and evolution by the birth-and-death process in the immunoglobulin VH gene family. Molecular Biology and Evolution, 11, 469-482.
63. Patten, P.E., Buggins, A.G., Richards, J., Wotherspoon, A., Salisbury, J., Mufti, G.J., Hamblin, T.J. & Devereux, S. (2008) CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood, 111, 5173-5181.
64. Philippé, J., Janssens, A., Smits, K., Mollet, I., Vandenbulcke, K., Speleman, F. & Offner, F. (2003) Prognostic value of specific VH-genes in CLL (Abstract). Leukaemia & Lymphoma, 44, S40.
65. Price, L.S. & Bos, J.L. (2004) RAPL: taking the Rap in immunity. Nature Immunology, 5, 1007-1008.
66. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. & Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
67. Reya, T., O'Riordan, M., Okamura, R., Devaney, E., Willert, K., Nusse, R. & Grosschedl, R. (2000) Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity, 13, 15-24.
68. Ribera, J.M., Vinolas, N., Urbano-Ispizua, A., Gallart, T., Montserrat, E. & Rozman, C. (1987) "Spontaneous" complete remissions in chronic lymphocytic leukemia: report of three cases and review of the literature. Blood Cells, 12, 471-483.
69. Schroeder, H.W., Jr & Dighiero, G. (1994) The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunology Today, 15, 288-294.
70. Schroeder, H.W., Jr., Hillson, J.L. & Perlmutter, R.M. (1990) Structure and evolution of mammalian VH families. International Immunology, 2, 41-50.
71. Schwartz, R.S. & Stollar, B.D. (1994) Heavy-chain directed B-cell maturation: continuous clonal selection beginning at the pre-B cell stage. Immunology Today, 15, 27-32.
72. Scrivener, S., Kaminski, E.R., Demaine, A. & Prentice, A.G. (2001) Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation. British Journal of Haematology, 112, 959-964.
73. Silverman, G.J. & Goodyear, C.S. (2002) A model B-cell superantigen and the immunobiology of B lymphocytes. Clinical Immunology, 102, 117-134.
74. Silverman, G.J. & Goodyear, C.S. (2006) Confounding B-cell defences: lessons from a staphylococcal superantigen. Nature Reviews. Immunology, 6, 465-475.
75. Silverman, G.J., Cary, S., Graille, M., Curtiss, V.E., Wagenknecht, R., Luo, L., Dwyer, D., Goodyear, C., Corper, A.L., Stura, E.A. & Charbonnier, J.B. (2000) A B-cell superantigen that targets B-1 lymphocytes. Current Topics in Microbiology and Immunology, 252, 251-263.
76. Stamatopoulos, K., Belessi, C., Moreno, C., Boudjograh, M., Guida, G., Smilevska, T., Belhoul, L., Stella, S., Stavroyianni, N., Crespo, M., Hadzidimitriou, A., Sutton, L., Bosch, F., Laoutaris, N., Anagnostopoulos, A., Montserrat, E., Fassas, A., Dighiero, G., Caligaris-Cappio, F., Merle-Beral, H., Ghia, P. & Davi, F. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood, 109, 259-270.
77. Sthoeger, Z.M., Wakai, M., Tse, D.B., Vinciguerra, V.P., Allen, S.L., Budman, D.R., Lichtman, S.M., Schulman, P., Weiselberg, L.R. & Chiorazzi, N. (1989) Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. Journal of Experimental Medicine, 169, 255-268.
78. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. & Mesirov, J.P. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 102, 15545-15550.
79. Thomas, R., Ribeiro, I., Shepherd, P., Johnson, P., Cook, M., Lakhani, A., Kaczmarski, R., Carrington, P. & Catovsky, D. (2002) Spontaneous clinical regression in chronic lymphocytic leukaemia. British Journal of Haematology, 116, 341-345.
80. Thorselius, M., Krober, A., Murray, F., Thunberg, U., Tobin, G., Buhler, A., Kienle, D., Albesiano, E., Maffei, R., Dao-Ung, L.P., Wiley, J., Vilpo, J., Laurell, A., Merup, M., Roos, G., Karlsson, K., Chiorazzi, N., Marasca, R., Dohner, H., Stilgenbauer, S. & Rosenquist, R. (2006) Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood, 107, 2889-2894.
81. Tobin, G., Thunberg, U., Johnson, A., Thorn, I., Soderberg, O., Hultdin, M., Botling, J., Enblad, G., Sallstrom, J., Sundstrom, C., Roos, G. & Rosenquist, R. (2002) Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood, 99, 2262-2264.
82. Tobin, G., Thunberg, U., Johnson, A., Eriksson, I., Soderberg, O., Karlsson, K., Merup, M., Juliusson, G., Vilpo, J., Enblad, G., Sundstrom, C., Roos, G. & Rosenquist, R. (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood, 101, 4952-4957.
83. Tobin, G., Thunberg, U., Karlsson, K., Murray, F., Laurell, A., Willander, K., Enblad, G., Merup, M., Vilpo, J., Juliusson, G., Sundstrom, C., Soderberg, O., Roos, G. & Rosenquist, R. (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood, 104, 2879-2885.
84. Upshaw, J.D., Jr & Callihan, T.R. (2002) Spontaneous remission of B-cell chronic lymphocytic leukemia associated with T lymphocytic hyperplasia in bone marrow. The Southern Medical journal, 95, 647-649.
85. Vargas-Madrazo, E., Lara-Ochoa, F., Ramirez-Benites, M.C. & Almagro, J.C. (1997) Evolution of the structural repertoire of the human V(H) and Vkappa germline genes. International Immunology, 9, 1801-1815.
86. Wang, Q., Sun, Z. & Yang, H.S. (2008) Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene, 27, 1527-1535.
87. Widhopf, II, G.F., Rassenti, L.Z., Toy, T.L., Gribben, J.G., Wierda, W.G. & Kipps, T.J. (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood, 104, 2499-2504.
88. Widhopf, G.F., Goldberg, C.J., Toy, T.L., Rassenti, L.Z., Wierda, W.G., Byrd, J.C., Keating, M.J., Gribben, J.G., Rai, K.R. & Kipps, T.J. (2008) Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood, 111, 3137-3144.
89. Wiernik, P.H. (1976) Spontaneous regression of hematologic cancers. Natl.Cancer Inst.Monogr, 44, 35-38.
90. Zucchetto, A., Sonego, P., Degan, M., Bomben, R., Dal, B.M., Bulian, P., Benedetti, D., Rupolo, M., Del, P.G., Campanini, R. & Gattei, V. (2006) Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance. Journal of Translational Medicine, 4, 11.
91. Zucchetto, A., Benedetti, D., Tripodo, C., Bomben, R., Dal, B.M., Marconi, D., Bossi, F., Lorenzon, D., Degan, M., Rossi, F.M., Rossi, D., Bulian, P., Franco, V., Del, P.G., Deaglio, S., Gaidano, G., Tedesco, F., Malavasi, F. & Gattei, V. (2009) CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Research, 69, 4001-4009.
92. Zucchetto, A., Tripodo, C., Benedetti, D., Deaglio, S., Gaidano, G., Del, P.G. & Gattei, V. (2010) Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38CD49d chronic lymphocytic leukaemia cells. British Journal of Haematology, 150, 111-112.